Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Praxis Precision Medicines (PRAX) FCF Margin: 2023-2025

Historic FCF Margin for Praxis Precision Medicines (PRAX) over the last 3 years, with Sep 2025 value amounting to -1,470.03%.

  • Praxis Precision Medicines' FCF Margin rose 763593.00% to -1,470.03% in Q3 2025 from the same period last year, while for Sep 2025 it was -1,028.40%, marking a year-over-year increase of 517073.00%. This contributed to the annual value of -1,540.48% for FY2024, which is 300329.00% up from last year.
  • According to the latest figures from Q3 2025, Praxis Precision Medicines' FCF Margin is -1,470.03%, which was down 32.82% from -1,106.80% recorded in Q2 2025.
  • Over the past 5 years, Praxis Precision Medicines' FCF Margin peaked at -752.00% during Q4 2024, and registered a low of -9,105.96% during Q3 2024.
  • Over the past 3 years, Praxis Precision Medicines' median FCF Margin value was -4,633.20% (recorded in 2023), while the average stood at -4,027.46%.
  • Its FCF Margin has fluctuated over the past 5 years, first tumbled by 413,481bps in 2024, then surged by 763,593bps in 2025.
  • Praxis Precision Medicines' FCF Margin (Quarterly) stood at -4,633.20% in 2023, then spiked by 388,120bps to -752.00% in 2024, then soared by 763,593bps to -1,470.03% in 2025.
  • Its FCF Margin was -1,470.03% in Q3 2025, compared to -1,106.80% in Q2 2025 and -977.06% in Q1 2025.